GEGinika Egesimba

Ginika Egesimba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ginika Egesimba has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Sierra Leone’s Elimination of Mother-to-child Transmission of HIV Program, 2024: The Need for a Life Course Approach to Triple Elimination

    by Mariama Mustapha, Ibrahim Turay, Finda P. Pessima, Francis K. Tamba, Semion Saffa-Turay, Gerald Younge, Veronica L. Deen, Eshetu Kebede Tabor, Tagoola Abner, Ginika Egesimba, et al.

    Background: The elimination of Mother-to-Child Transmission (eMTCT) Cascade Analysis is a key intervention to understand the effectiveness and gaps in national HIV prevention programs for pregnant women and their infants. This comprehensive evaluation aimed to assess the step-by-step processes of eMTCT services, from the entry points at antenatal care (ANC) to outcomes for HIV-exposed infants (HEI) and propose actionable recommendations using the life course approach to improve maternal and child health outcomes in Sierra Leone. Methods: We used a retrospective cohort study to understand the entry of HIV-positive pregnant women into the eMTCT program and the outcome of their infants. The assessment was conducted in June 2024 across 118 selected health facilities nationwide. Data was analysed using Microsoft Excel to assess the steps from entry into the eMTCT program to HIV testing outcomes and delivery process for infants, including final infant/child outcomes for HIV-positive pregnant and breastfeeding women. Results: Of the 80,264 pregnant women attending their first ANC visit between January and December 2022, 74,401(92.7%) received HIV tests. Of the 2,083 newly diagnosed HIV-positive pregnant women, 1,612 (77.4%) were initiated on antiretroviral therapy (ART) at their first ANC visit, highlighting a critical gap where 22.6% missed early treatment initiation. Only 753 (36.1%) HIV-positive women had documented facility-based delivery, indicating significant drop-offs in retention and continuity of care. Among 761 HEIs, 671 (88.2%) received ART for prophylaxis within 72 hours of birth; however, only 466 (61.2%) underwent their first virological test within 6-8 weeks of birth, and 176 (24.1%) received a second virological test 12 weeks after cessation of breastfeeding. Conclusion: While Sierra Leone’s eMTCT program has made substantial progress in ANC attendance and HIV testing, critical gaps persist in ART initiation, facility delivery of HIV-positive women and retention in care. Adopting a life course approach is critical to address these gaps through targeted interventions, improved data quality, and enhanced follow-up care.


  • Open Access

    Evidence of health-system resilience in the uptake of antiretroviral therapy in Sierra Leone during the COVID-19 pandemic: a nationwide retrospective study

    by Jarieu Tucker, Joseph Marah, Ginika Egesimba, Zeleke Abebaw Mekonnen, Hannah Sheriff, Bailah Molleh, Stephen Sevalie, Adrienne K. Chan, Sharmistha Mishra, Sulaiman Lakoh

    Background: Sustained access to and uptake of antiretroviral therapy (ART) among people living with HIV is a critical component of the HIV response. Limited data exist evaluating the extent to which the COVID-19 pandemic may have disrupted HIV treatment services in Sierra Leone. This study aims to describe differential patterns in the uptake of ART before, during, and after the COVID-19 emergency period in the country. Methods: We conducted a retrospective cross-sectional study using aggregated secondary program data extracted from the national health information system to reflect the uptake of ART in three time periods: March 2019-February 2020 (pre-COVID-19); March 2020-February 2021 (during COVID-19) and March 2021- February 2022 (post COVID-19). Outcomes were compared across the three time periods and stratified by sex and by region. Results: There was a steady increase in the overall ART uptake from 365,326 pre-COVID-19 to 416,069 during COVID-19 and 518, 426 post-COVID-19, which masks the more significant relative decline affecting new ART initiations due to COVID-19: pre-COVID-19 (8, 958), during COVID-19 (8,777), and post-COVID-19 (13, 996). A sharp decline in new ART initiation was consistent with the surge in COVID-19, reflected geographical variability, but showed no sex difference. Conclusion: Variations on the impact of COVID-19 across regions underscores the need for targeted interventions to mitigate the impact of future structural shocks on HIV services. The steady increase in overall uptake of ART suggests resiliency to a significant disruption and reflects pre-emptive health systems adaptations. The notable increase in new initiations in the post-COVID-19 period could suggest catch-up of delayed new initiations or more also reflect increasing HIV incidence and the critical importance of sustained investments for resiliency.


  • Open Access

    Impact of COVID-19 on the Utilization of HIV Testing and Linkage Services in Sierra Leone: Experience from Three Public Health Facilities in Freetown

    by Sulaiman Lakoh, Moses M. Bangura, Olukemi Adekanmbi, Umu Barrie, Darlinda F. Jiba, Matilda N. Kamara, Daniel Sesay, Abdulai Tejan Jalloh, Gibrilla F. Deen, James B. W. Russell, et al.

    The COVID-19 pandemic adversely affected the delivery of essential health services globally. In this study, we aimed to assess the impact of the pandemic on HIV testing and linkage services at three public health facilities in Freetown, Sierra Leone. We conducted a retrospective study to assess the impact of COVID-19 on HIV testing and linkage to treatment services (HTS) at Connaught Hospital (CH-tertiary), Lumley Government Hospital (LGH-secondary) and George Brooke Community Health Center (GBC-primary) in Freetown. Statistical analyses were conducted in Stata (16.1, StataCorp LLC, College Station, TX). Intra-pandemic HTS (2020) and HTS during recovery (2021) were compared with pre-pandemic HTS (2019). Of the 8538 people tested for HIV in the three facilities, 4929 (57.5%) visited CH. Only 2249 people were tested for HIV in 2020 compared to 3825 in 2019 (difference: − 41.2%, P < 0.001). Fewer people were also tested in 2021 (difference: − 35.6% P < 0.001). The largest reductions in testing in 2020 occurred in women (− 47.7%), children under 15 (− 95.2%), married people (− 42.6%), and CH (− 46.2%). Overall, 1369 (16.0%) people were positive for HIV; CH (878, 17.9%), LGH (469, 15.6%) and GBC (22, 3.5%). The likelihood of a positive HIV test was 26% lower in 2020 than 2019 (PR 0.74; 95% CI 0.64–0.85; P < 0.001), but 16% higher in 2021 than 2019 (PR 1.16; 95% CI 1.03–1.30; P < 0.05). Of the 1369 HIV diagnosis, 526 (38.4%) were linked to care. We found significant disruptions in HIV testing and linkage services at different levels of service delivery during the COVID-19 pandemic, underscoring the need to strengthen essential health services during public health emergencies.